MNPR - Wall Street Estimates - Monopar Therapeutics Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 32.775

-6.65 %

$ 200 M

Market Cap

-16.55

P/E

Price Target Average

--9.99%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

73.39%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Monopar Therapeutics Inc.

Wall Street analysts predict an average 1-year price target for MNPR of $29.5 , with forecasts ranging from a low of $22 to a high of $37 .

MNPR Lowest Price Target Wall Street Target

22 USD -32.88%

MNPR Average Price Target Wall Street Target

29.5 USD -9.99%

MNPR Highest Price Target Wall Street Target

37 USD 12.89%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free